SHL Telemedicine Ltd. (NASDAQ:SHLT) Short Interest Up 62.5% in March

SHL Telemedicine Ltd. (NASDAQ:SHLT - Get Free Report) saw a large increase in short interest in March. As of March 31st, there was short interest totalling 2,600 shares, an increase of 62.5% from the March 15th total of 1,600 shares. Based on an average daily trading volume, of 3,900 shares, the short-interest ratio is currently 0.7 days.

SHL Telemedicine Trading Down 4.2 %

SHLT stock traded down $0.25 during midday trading on Friday, reaching $5.58. The stock had a trading volume of 1,123 shares, compared to its average volume of 6,364. The company's fifty day simple moving average is $6.24 and its 200 day simple moving average is $8.02. SHL Telemedicine has a 52-week low of $5.52 and a 52-week high of $12.75.

Wall Street Analyst Weigh In

Separately, Litchfield Hills Research reaffirmed a "buy" rating and issued a $11.00 price target on shares of SHL Telemedicine in a research note on Thursday, March 14th.

About SHL Telemedicine

SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. It offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen'C, a personal cellular-digital 12-lead ECG transmitter device; Cardio'B, a portable device to transmit a 12-lead ECG; and Cardio Beeper 12/12, a hand-held ECG transmitter device for personal use that transmits a full ECG reading to the monitoring center.